CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Institut Simo Milosevic A.D. Igalo Company Snapshot
Institut Simo Milosevic A.D. Igalo operates within the Specialty hospitals exc. psychiatric sector. In addition to historical fundamental analyses, the complete report available to purchase compares Institut Simo Milosevic A.D. Igalo with three other health care providers in Europe: Institut Stvolovykh Kletok Cheloveka PAO of Russia (2017 sales of 494.44 million Russian Rubles [US$7.28 million] ), Dom Lekarski SA of Poland (40.21 million Polish New Zlotys [US$10.63 million] ), and Swissmed Centrum Zdrowia SA which is also based in Poland (37.07 million Polish New Zlotys [US$9.80 million] ).

Sales Analysis. During the year ended December of 2017, sales at Institut Simo Milosevic A.D. Igalo were 10.25 million Euro (US$11.62 million). This is an increase of 6.9% versus 2016, when the company's sales were 9.59 million Euro. The sales level in 2017 was fairly close to the level five years ago: in 2012, Institut Simo Milosevic A.D. Igalo had sales of 9.67 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Institut Simo Milosevic A.D. Igalo
  Stock Performance Chart for Institut Simo Milosevic A.D. Igalo
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 33.00
(Figures in Euro)
1 Week n/a   13 Weeks n/a  
4 Weeks 17.9%   52 Weeks n/a  
 
Institut Simo Milosevic A.D. Igalo Key Data:
  Ticker: INSM Country: Montenegro
  Exchanges: OTH Major Industry: Health Care Equipment & Services
    Sub Industry: Specialty Hospitals Exc. Psychiatric
  2017 Sales 10,251,190
(Year Ending Jan 2018).
Employees: 738
  Currency: Euro Market Cap: 12,617,583
  Fiscal Yr Ends: December Shares Outstanding: 382,351
  Share Type: Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.